Global In-Vitro Diagnostics Market was valued at US$ 68.92 billion in 2018 and is anticipated to reach US$ 98.18 billion by 2025 displaying a reasonable CAGR of 5.24% over the forecast period (2019-2025). Global In-Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to detect infection, diagnose a medical condition, prevent disease and monitor drug therapies. The market of In-Vitro Diagnostics market is anticipated to grow enormously owing to factors such as rising geriatric population, increasing prevalence of chronic diseases, increasing adoption of Point-of-care diagnosis, and technology advancement in the In-Vitro Diagnostics technology. Rising demand for Point-of-Care (POC) devices is expected to fuel the market growth in near future. In addition, introduction of advanced technologies, such as biochips and nano-biotechnology, and miniaturization of microfluidics are expected to increase the demand for PoC products. These advancements have enabled easy access to PoC diagnostic tests and are likely to facilitate quick and effective test results, thereby boosting the overall market growth. The changing reimbursement models and regulations, investing in unifying technology would mark as a trend in this industry. However, stringent government regulations for the manufacturing of IVD products will act as the major challenges in the growth of this market. Factors Influencing IVD Companies’ Business Models “Reagents dominated the product segment of the global In-Vitro Diagnostics market with 69.0% share in 2018” Based on Product type the global in-vitro diagnostics market is segmented into reagents and Instruments Services. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to its high demand in over-the-counter diagnostic tests, paired with rising demand of these for tests at non-medical facilities such as home. “Immunoassay technique of In-Vitro Diagnostic dominated the market in 2018” Based on techniques the global In-Vitro Diagnostics market is segmented into Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology, Microbiology, Point-of-Care and Hemostasis. The Immunoassay technique occupied the largest share of 24.7% in 2018 and is expected to maintain its dominance throughout the forecast period 2019-2025. However, Molecular Diagnostics and Point-of-Care testing techniques are expected to witness highest CAGR growth during the analyzed period, owing to increasing demand for such tests at home. “In-Vitro Diagnostic technology was majorly applied for the treatment or diagnosis of Infectious Disease” Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases are the major applications of In-Vitro Diagnostics technology. In 2018, IVD was majorly used for the treatment and diagnosis of Infectious Diseases. The segment is expected to witness CAGR 4.89% during the forecast period 2019-2025 to generate revenue of US$ 33.73 billion by 2025. However, Oncology treatment using IVD is expected to grow at the highest rate during the analyzed period. In-Vitro Diagnostics Market Size, by Application, Global, 2018-25 (US$ Bn) “Hospitals were the major end-users of In-Vitro Diagnostic technology in 2018” Based on end-users, the global In-Vitro Diagnostics market is bifurcated into hospitals, clinics & labs, home care and other healthcare facilities. In 2018, hospital segment occupied 47.6% share. However, use of the technology for home disease treatment is expected to witness highest CAGR growth dusting the forecast period 2019-2025. The growing elderly population and associated diseases would help the segment to witness such growth. “Reusable IVD Devices are expected to dominate the usability segment of the global in-vitro diagnostics market during the analyzed period.” In-Vitro Diagnostics market segmented based on usability include reusable and disposable IVD devices. The Reusable IVD Devices occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025. “North America represents one of the largest markets of In-Vitro Diagnostics market globally in 2018” For a deep-dive analysis of the industry and its adoption rate, detailed regional/country-level analysis was conducted for regions including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of the World (Brazil and Others). In 2018, North America dominated the market, however growing elderly population in Europe and Asia-Pacific would help the region to use more of in-vitro diagnostic technology for disease detection and treatment. Competitive Landscape-Top 10 Market Players Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific are some of the prominent players operating in the Global In-Vitro Diagnostics market industry. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products in the In-Vitro Diagnostic sector. Reasons to buy (The research report presents): Current and future market size from 2018 to 2025 in terms of value (US$)

Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry

Country-level details of the overall adoption of the In-Vitro Diagnostics market

A quick review of overall industry performance at a glance

In-depth analysis of key industry players

A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry

Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start-ups

The study comprehensively covers the market across different segments and sub-segments of the technology

Region/country Covered: North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of the World (Brazil and Others) Customization Options: The Global In-Vitro Diagnostics Market can be customized to the country level or any other market segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients.

1.1 Market Definition 1.2 Objective of the Study 1.3 Limitation 1.4 Stakeholders 1.5 Currency used in the Report 1.6 Scope of the Global In-Vitro Diagnostics Market Study 2 RESEARCH METHODOLOGY 2.1 Research Methodology for Global In-Vitro Diagnostics Market Study 2.1.1 Main objective of the Global In-Vitro Diagnostics Market Study 3 COMPREHENSIVE ASSESSMENT OF THE VALUE OF DIAGNOSTIC TESTS 3.1 General Overview 3.2 Capturing the full spectrum of the value that a diagnostic test contributes 3.3 Ensuring that robust analyses underpin the value assessment 3.4 Accounting for variation in diagnostic test types in value assessment methods 3.5 Aligning on how to define and measure value drivers 3.5.1 Value Driver: Clinical Impact 3.5.2 Value Driver: Non-Clinical Patient Impact 3.5.3 Value Driver: Care Delivery Revenue and Cost Impact 3.5.4 Value Driver: Public/Population Impact 4 REFRAMING THE DIAGNOSTICS INDUSTRY 4.1 General Overview 4.2 The key to accountable adoption of in vitro diagnostic technologies 4.2.1 Drivers of diagnostic technology innovation and adoption: 4.2.2 Current Challenges for Diagnostic Innovation 4.2.2.1 Regulation 4.2.2.2 Evidence generation 4.2.2.3 Clinical needs 4.2.2.4 Commissioning 4.2.2.5 Adoption 4.2.3 Current needs 4.2.3.1 Three key questions for diagnostic innovation: 4.2.4 Developing an evidence ‘toolkit’ for diagnostic test research 4.3 Value of Diagnostics to Health Care and Health Status 5 COSTS AND BENEFITS OF DIAGNOSTIC TESTING 5.1 General Overview 5.2 Introduction and problem statement 5.2.1 Increasing healthcare costs 5.2.2 Underutilization of IVDs in clinical practice 5.3 Consequences for patient care 5.3.1 Conceptual interventions 5.3.1.1 Fostering prevention, screening, early diagnosis, and therapy 5.3.1.2 Promoting comprehensive disease management 5.3.1.3 Promoting stratified disease management 5.3.1.4 Targeted delivery of treatment alongside companion diagnostics 5.4 Consequences for policies: promoting a fee for outcomes 5.5 Analysis 5.6 Conclusion 6 RISK MITIGATION 6.1 General Overview 6.2 Supply Chain 6.3 Risk Assessment 6.4 Bulk, Custom and Contract Manufacturing 7 CURRENT AND FUTURE USE OF DIAGNOSTIC PRODUCTS 7.1 Primary Uses of Diagnostics 7.1.1 Predictive Applications/Screening/Early Disease Detection 7.1.2 Diagnostic 7.1.3 Secondary Risk Assessment – Prognostic 7.1.4 Drug Selection/Treatment Targeting 7.1.5 Disease/Condition Monitoring and Management 7.2 In Vitro Diagnostics: Overview of Future Trends and Directions 7.2.1 Predict Disease Before Symptoms Appear 7.2.2 Predict Beneficial and Adverse Treatment Effects 7.2.3 Enable Personalized “Real-Time” Treatment and Disease Management Regimens 7.2.4 Facilitate Point-of-care and Near-patient Testing 7.2.5 Enable Home Testing 7.2.6 Public Health, Environmental, Bioterrorism Applications 7.2.7 Technology and Testing System Integration 7.3 The importance of diagnostics 7.3.1 The role of diagnostics 7.3.2 Improving patient care 7.3.3 Reducing healthcare spending 7.3.4 Reasons In Vitro Diagnostics Are Superior 7.3.4.1 Quick Results 7.3.4.2 Multiple Tests at the Same Time 7.3.4.3 Customizable to Detect Different Chemicals 7.3.4.4 Ease of Recording the Data 7.3.4.5 Reliable Results That Can Be Quickly Repeated 8 EXECUTIVE SUMMARY 9 INDUSTRY PERFORMANCE 10 MARKET OVERVIEW 10.1 Introduction of In-Vitro Diagnostics Market 10.1.1 Essential Components or Attributes of Diagnostics 10.1.2 Main Categories of Diagnostics 10.1.3 Settings of Use 10.2 Market Dynamics 10.2.1 Market Drivers 10.2.1.1 Increasing prevalence of Chronic Diseases 10.2.1.2 Rising geriatric population 10.2.1.3 Increasing adoption of Point-of-Care Diagnosis 10.2.1.4 Technology Advancement in the In-vitro Diagnostics 10.2.2 Market Restraints 10.2.2.1 Stringent Government Regulations for the Manufacturing of IVD Products 10.2.2.2 Unfavourable Reimbursement Policies for In-vitro Diagnostics 10.2.3 Market Opportunities 10.2.3.1 Development of Condition-Specific Markers and Tests 10.2.3.2 Growing significance of Companion Diagnostics 10.2.4 Market Trends 10.2.4.1 Changing Reimbursement Models and Regulations 10.2.4.2 Investing in Unifying Technology 10.2.4.3 Consolidation and Automation of Labs 10.2.4.4 Shift to data-driven Healthcare 10.2.4.5 Consumer Lab Testing 10.2.4.6 Healthcare Convergence 11 REGULATIONS AND REIMBURSEMENT POLICY 11.1 United States 11.2 Europe 11.3 China 11.4 India 11.5 Japan 11.6 Australia 12 KEY MARKET INDICATORS 12.1 Demand Side Analysis 12.1.1 Key Facts on Aging Population 12.1.2 Health Conditions Associated with Aging 12.1.2.1 Some of the key facts about Cardiovascular Diseases (CVD) 12.2 Supply Side Analysis 12.2.1 Product Launches 12.2.2 Partnerships 12.2.3 Business Expansion and Investments 12.2.4 Mergers and Acquisitions 12.2.5 SWOT Analysis of In-Vitro Diagnostics Market 12.2.6 Value Chain Analysis of In-Vitro Diagnostics 13 ROLE OF IN-VITRO DIAGNOSTICS IN HEALTHCARE 13.1 General Overview 14 MARKET INSIGHT BY PRODUCT 14.1 General Overview 14.1.1 Reagents 14.1.2 Instruments Services 15 MARKET INSIGHT BY TECHNIQUES 15.1 General Overview 15.1.1 Immunoassay 15.1.2 Clinical Chemistry 15.1.3 Self-Monitoring of Blood Glucose (SMBG) 15.1.4 Molecular Diagnostics 15.1.5 Hematology 15.1.6 Microbiology 15.1.7 Point-of-Care 15.1.8 Hemostasis 16 MARKET INSIGHT BY APPLICATION 16.1 General Overview 16.1.1 Infectious Disease 16.1.2 Diabetes 16.1.3 Oncology 16.1.4 Cardiology 16.1.5 Nephrology 16.1.6 Autoimmune Disease 16.1.7 Others 17 MARKET INSIGHT BY END-USER 17.1 General Overview 17.1.1 Hospital In-Vitro Diagnostic 17.1.2 Clinics & Laboratory In-Vitro Diagnostic 17.1.3 Home Care In-Vitro Diagnostic Market 17.1.4 Others Healthcare Facility In-Vitro Diagnostic 18 MARKET INSIGHT BY USABILITY 18.1 General Overview 18.1.1 Disposable IVD Devices 18.1.2 Reusable IVD Devices 19 MARKET INSIGHT BY REGION 19.1 General Overview 19.2 North America IVD Market Insight 19.2.1 North America In-Vitro Diagnostics Market by Product 19.2.2 North America In-Vitro Diagnostics Market by Technique 19.2.3 North America In-Vitro Diagnostics Market by Application 19.2.4 North America In-Vitro Diagnostics Market by End-Users 19.2.5 North America In-Vitro Diagnostics Market by Usability 19.2.6 North America In-Vitro Diagnostics Market by Country 19.2.6.1 United States 19.2.6.1.1 Key Findings on Healthcare Spending in the US, 2017 19.2.6.1.2 US Health Spending by Type of Service or Product, 2017 19.2.6.1.3 Health Spending by Major Sources of Funds 19.2.6.1.4 United States In-Vitro Diagnostics Market by Product 19.2.6.1.5 United States In-Vitro Diagnostics Market by Technique 19.2.6.1.6 United States In-Vitro Diagnostics Market by Application 19.2.6.1.7 United States In-Vitro Diagnostics Market by End-Users 19.2.6.1.8 United States In-Vitro Diagnostics Market by Usability 19.2.6.2 Canada 19.2.6.2.1 Key Findings on Canada Healthcare Spending, 2018 19.2.6.2.2 Key Findings on Hospital sector Spending in Canada, 2017 19.2.6.2.3 Canada In-Vitro Diagnostics Market by Product 19.2.6.2.4 Canada In-Vitro Diagnostics Market by Technique 19.2.6.2.5 Canada In-Vitro Diagnostics Market by Application 19.2.6.2.6 Canada In-Vitro Diagnostics Market by End-Users 19.2.6.2.7 Canada In-Vitro Diagnostics Market by Usability 19.2.6.3 Rest of North America 19.2.6.3.1 Rest of NA In-Vitro Diagnostics Market by Product 19.2.6.3.2 Rest of NA In-Vitro Diagnostics Market by Technique 19.2.6.3.3 Rest of NA In-Vitro Diagnostics Market by Application 19.2.6.3.4 Rest of NA In-Vitro Diagnostics Market by End-Users 19.2.6.3.5 Rest of NA In-Vitro Diagnostics Market by Usability 19.3 Europe IVD Market Insight 19.3.1 Europe In-Vitro Diagnostics Market by Product 19.3.2 Europe In-Vitro Diagnostics Market by Technique 19.3.3 Europe In-Vitro Diagnostics Market by Application 19.3.4 Europe In-Vitro Diagnostics Market by End-Users 19.3.5 Europe In-Vitro Diagnostics Market by Usability 19.3.6 Europe In-Vitro Diagnostics Market by Country 19.3.6.1 Germany 19.3.6.1.1 Germany In-Vitro Diagnostics Market by Product 19.3.6.1.2 Germany In-Vitro Diagnostics Market by Technique 19.3.6.1.3 Germany In-Vitro Diagnostics Market by Application 19.3.6.1.4 Germany In-Vitro Diagnostics Market by End-Users 19.3.6.1.5 Germany In-Vitro Diagnostics Market by Usability 19.3.6.2 France 19.3.6.2.1 France In-Vitro Diagnostics Market by Product 19.3.6.2.2 France In-Vitro Diagnostics Market by Technique 19.3.6.2.3 France In-Vitro Diagnostics Market by Application 19.3.6.2.4 France In-Vitro Diagnostics Market by End-Users 19.3.6.2.5 France In-Vitro Diagnostics Market by Usability 19.3.6.3 Spain 19.3.6.3.1 Spain In-Vitro Diagnostics Market by Product 19.3.6.3.2 Spain In-Vitro Diagnostics Market by Technique 19.3.6.3.3 Spain In-Vitro Diagnostics Market by Application 19.3.6.3.4 Spain In-Vitro Diagnostics Market by End-Users 19.3.6.3.5 Spain In-Vitro Diagnostics Market by Usability 19.3.6.4 Italy 19.3.6.4.1 Italy In-Vitro Diagnostics Market by Product 19.3.6.4.2 Italy In-Vitro Diagnostics Market by Technique 19.3.6.4.3 Italy In-Vitro Diagnostics Market by Application 19.3.6.4.4 Italy In-Vitro Diagnostics Market by End-Users 19.3.6.4.5 Italy In-Vitro Diagnostics Market by Usability 19.3.6.5 United Kingdom 19.3.6.5.1 United Kingdom In-Vitro Diagnostics Market by Product 19.3.6.5.2 United Kingdom In-Vitro Diagnostics Market by Technique 19.3.6.5.3 United Kingdom In-Vitro Diagnostics Market by Application 19.3.6.5.4 United Kingdom In-Vitro Diagnostics Market by End-Users 19.3.6.5.5 United Kingdom In-Vitro Diagnostics Market by Usability 19.3.6.6 Rest of Europe 19.3.6.6.1 Rest of Europe In-Vitro Diagnostics Market by Product 19.3.6.6.2 Rest of Europe In-Vitro Diagnostics Market by Technique 19.3.6.6.3 Rest of Europe In-Vitro Diagnostics Market by Application 19.3.6.6.4 Rest of Europe In-Vitro Diagnostics Market by End-Users 19.3.6.6.5 Rest of Europe In-Vitro Diagnostics Market by Usability 19.4 Asia-Pacific In-Vitro Diagnostics Market Insight 19.4.1 Asia-Pacific In-Vitro Diagnostics Market by Product 19.4.2 Asia-Pacific In-Vitro Diagnostics Market by Technique 19.4.3 Asia-Pacific In-Vitro Diagnostics Market by Application 19.4.4 Asia-Pacific In-Vitro Diagnostics Market by End-Users 19.4.5 Asia-Pacific In-Vitro Diagnostics Market by Usability 19.4.6 Asia-Pacific In-Vitro Diagnostics Market by Country 19.4.6.1 China 19.4.6.1.1 IVD Product Registration in China 19.4.6.1.2 China IVD Type Testing Process 19.4.6.1.3 Clinical Trials for IVD Products in China 19.4.6.1.4 Reimbursement of IVD Products in China 19.4.6.1.5 China In-Vitro Diagnostics Market by Product 19.4.6.1.6 China In-Vitro Diagnostics Market by Technique 19.4.6.1.7 China In-Vitro Diagnostics Market by Application 19.4.6.1.8 China In-Vitro Diagnostics Market by End-Users 19.4.6.1.9 China In-Vitro Diagnostics Market by Usability 19.4.6.2 India 19.4.6.2.1 Notified Medical Devices 19.4.6.2.2 Non-Notified Medical Devices 19.4.6.2.3 India In-Vitro Diagnostics Market by Product 19.4.6.2.4 India In-Vitro Diagnostics Market by Technique 19.4.6.2.5 India In-Vitro Diagnostics Market by Application 19.4.6.2.6 India In-Vitro Diagnostics Market by End-Users 19.4.6.2.7 India In-Vitro Diagnostics Market by Usability 19.4.6.3 Japan 19.4.6.3.1 Classification of IVDs in Japan 19.4.6.3.2 Category of Approval Applications for IVD Reagents 19.4.6.3.3 Japan In-Vitro Diagnostics Market by Product 19.4.6.3.4 Japan In-Vitro Diagnostics Market by Technique 19.4.6.3.5 Japan In-Vitro Diagnostics Market by Application 19.4.6.3.6 Japan In-Vitro Diagnostics Market by End-Users 19.4.6.3.7 Japan In-Vitro Diagnostics Market by Usability 19.4.6.4 Australia 19.4.6.4.1 Australia In-Vitro Diagnostics Market by Product 19.4.6.4.2 Australia In-Vitro Diagnostics Market by Technique 19.4.6.4.3 Australia In-Vitro Diagnostics Market by Application 19.4.6.4.4 Australia In-Vitro Diagnostics Market by End-Users 19.4.6.4.5 Australia In-Vitro Diagnostics Market by Usability 19.4.6.5 Rest of Asia-Pacific Market Insight 19.4.6.5.1 Rest of APAC In-Vitro Diagnostics Market by Product 19.4.6.5.2 Rest of APAC In-Vitro Diagnostics Market by Technique 19.4.6.5.3 Rest of APAC In-Vitro Diagnostics Market by Application 19.4.6.5.4 Rest of APAC In-Vitro Diagnostics Market by End-Users 19.4.6.5.5 Rest of APAC In-Vitro Diagnostics Market by Usability 19.5 Rest of World Market Insight 19.5.1 Rest of World In-Vitro Diagnostics Market by Product 19.5.2 Rest of World In-Vitro Diagnostics Market by Technique 19.5.3 Rest of World In-Vitro Diagnostics Market by Application 19.5.4 Rest of World In-Vitro Diagnostics Market by End-Users 19.5.5 Rest of World In-Vitro Diagnostics Market by Usability 19.5.6 Rest of World In-Vitro Diagnostics Market by Country 19.5.6.1 Brazil 19.5.6.1.1 Brazil In-Vitro Diagnostics Market by Product 19.5.6.1.2 Brazil In-Vitro Diagnostics Market by Technique 19.5.6.1.3 Brazil In-Vitro Diagnostics Market by Application 19.5.6.1.4 Brazil In-Vitro Diagnostics Market by End-Users 19.5.6.1.5 Brazil In-Vitro Diagnostics Market by Usability 19.5.6.2 Other Rest of World 19.5.6.2.1 Other Rest of World In-Vitro Diagnostics Market by Product 19.5.6.2.2 Other Rest of World In-Vitro Diagnostics Market by Technique 19.5.6.2.3 Other Rest of World In-Vitro Diagnostics Market by Application 19.5.6.2.4 Other Rest of World In-Vitro Diagnostics Market by End-Users 19.5.6.2.5 Other Rest of World In-Vitro Diagnostics Market by Usability 20 COMPETITIVE SCENARIO 20.1 Porter’s Five forces analysis 20.1.1 Bargaining Power of Suppliers 20.1.2 Bargaining Power of Buyers 20.1.3 Threat of New Entrants 20.1.4 Threat of Substitutes 20.1.5 Industry Rivalry 20.2 Market Share Analysis, by Company 20.2.1 Global In-Vitro Diagnostic Market Share Analysis, by Company 2018 21 TOP COMPANY PROFILES 21.1 Abbott Laboratories 21.1.1 Key Facts 21.1.2 Business Description 21.1.3 Key Product/Services Offerings 21.1.4 Growth Strategy 21.1.5 SWOT Analysis 21.1.6 Key Financials 21.1.6.1 Revenue Split 21.1.7 Recent Developments 21.1.7.1 Product Launches 21.1.7.2 Partnership 21.1.7.3 Merger and Acquisition 21.2 Becton Dickinson 21.2.1 Key Facts 21.2.2 Business Description 21.2.3 Key Product/Services Offerings (AI Technology) 21.2.4 Growth Strategy 21.2.5 SWOT Analysis 21.2.6 Key Financials 21.2.6.1 Revenue Split 21.2.7 Recent Developments 21.2.7.1 Product Launch 21.2.7.2 Partnerships 21.2.7.3 Business Expansions and Investments 21.2.7.4 Merger & Acquisitions 21.3 Biomérieux SA 21.3.1 Key Facts 21.3.2 Business Description 21.3.3 Key Product/Services Offerings 21.3.4 Growth Strategy 21.3.5 SWOT Analysis 21.3.6 Key Financials 21.3.6.1 Revenue Split 21.3.7 Recent Developments 21.3.7.1 Product Launches 21.3.7.2 Partnerships 21.3.7.3 Mergers and Acquisitions 21.4 Bio-Rad Laboratories, Inc. 21.4.1 Key Facts 21.4.2 Business Description 21.4.3 Key Product/Services Offerings 21.4.4 Growth Strategy 21.4.5 SWOT Analysis 21.4.6 Key Financials 21.4.6.1 Revenue Split 21.4.7 Recent Developments 21.4.7.1 Product Launches 21.4.7.2 Mergers and Acquisitions 21.5 Danaher Corporation 21.5.1 Key Facts 21.5.2 Business Description 21.5.3 Key Product/Services Offerings 21.5.4 Growth Strategy 21.5.5 SWOT Analysis 21.5.6 Key Financials 21.5.6.1 Revenue Split 21.5.7 Recent Developments 21.5.7.1 Merger and Acquisitions 21.6 Johnson & Johnson 21.6.1 Key Facts 21.6.2 Business Description 21.6.3 Key Product/Services Offerings 21.6.4 Growth Strategy 21.6.5 SWOT Analysis 21.6.6 Key Financials 21.6.6.1 Revenue Split 21.7 Roche Holding AG 21.7.1 Key Facts 21.7.2 Business Description 21.7.3 Key Product/Services Offerings 21.7.4 Growth Strategy 21.7.5 SWOT Analysis 21.7.6 Key Financials 21.7.6.1 Revenue Split 21.7.7 Recent Developments 21.7.7.1 Product Launches 21.7.7.2 Partnership 21.7.7.3 Mergers and Acquisitions 21.8 Siemens Healthineers AG. 21.8.1 Key Facts 21.8.2 Business Description 21.8.3 Key Product/Services Offerings 21.8.4 Growth Strategy 21.8.5 SWOT Analysis 21.8.6 Key Financials 21.8.6.1 Revenue Split 21.8.7 Recent Developments 21.8.7.1 Product Launches 21.8.7.2 Partnership 21.8.7.3 Business Expansion and Investment 21.8.7.4 Merger and Acquisitions 21.9 Thermo Fisher Scientific 21.9.1 Key Facts 21.9.2 Business Description 21.9.3 Key Product/Services Offerings 21.9.4 Growth Strategy 21.9.5 SWOT Analysis 21.9.6 Key Financials 21.9.6.1 Revenue Split 21.9.7 Recent Developments 21.9.7.1 Product Launch 21.9.7.2 Partnerships 21.9.7.3 Business Expansion and Investment 21.9.7.4 Merger and Acquisition 21.10 Sysmex Corporation 21.10.1 Key Facts 21.10.2 Business Description 21.10.3 Key Product/Services Offerings 21.10.4 SWOT Analysis 21.10.5 Growth Strategy 21.10.6 Key Financials 21.10.6.1 Revenue Split 21.10.7 Recent Developments 21.10.7.1 Product Launches 21.10.7.2 Partnership 21.10.7.3 Business Expansion & Investments 21.10.7.4 Merger and Acquisitions

Analyzing historical market, estimation of the current market and forecasting the future market for Global In-Vitro Diagnostics were the three major steps undertaken to create and analyze the overall adoption of in-vitro diagnostic services in major regions/countries. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the In-Vitro Diagnostics technology. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of In-Vitro Diagnostics market globally. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the overall market size of segments and sub-segments of the technology. Detailed methodology is explained below: Analysis of Historical Market Size Step 1: In-Depth Study of Secondary Sources: Detail secondary study was conducted to obtain the historical market size of the Global In-Vitro Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publications. For economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used. Step 2: Market Segmentation: After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global In-Vitro Diagnostics technology. Major segments included in the report are product, techniques, applications, end-users and usability. Step 3: Factor Analysis: After acquiring the historical market size of different segments detailed factor analysis was conducted to estimate the current market size of the Global In-Vitro Diagnostics technology. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global In-Vitro Diagnostics technology and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied. Current Market Size Estimate & Forecast Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews. Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, opportunities and trends. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments of the technology. The research methodology adopted to estimate the market size encompasses: The industry’s market size, in terms of value and rate of adoption of In-Vitro Diagnostics globally

All percentage shares, splits, and breakdowns of market segments and sub-segments

Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global In-Vitro Diagnostics market Market Size and Share Validation Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarised, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights. Split of Primary Participants Market Engineering Data triangulation technique was employed to complete the overall market engineering process and to arrive precise statistical numbers of each segment and sub-segment pertaining to the Global In-Vitro Diagnostics market. Data was split into several segments post studying various parameters and trends in areas such as product, techniques, applications, end-user, usability and regions such as North America, Europe, Asia-Pacific and Rest of the World. Main objective of the In-Vitro Diagnostics Market Study The current & future market trends of the Global In-Vitro Diagnostics market are pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market, providing a platform for the industrial participant to exploit the untapped market to benefit as first-mover advantage. Other quantitative goals of the studies include: Analyze the current and forecast market size of the global in-vitro diagnostics market in terms of value (US$)

Analyze the current and forecast market size of different segments and sub-segments of the global in-vitro diagnostics market

To analyze the revenue and business models of the market players in the industry

To understand the initiatives undertaken by diagnostics companies Vs. service providers to increase the overall analysis of in-vitro diagnostics in major regions

Define and describe the segments and sub-segments considered in the evaluation of the global in-vitro diagnostics market and anticipate potential risk associated with the market

Define and analysis of the government regulations for diagnostics

Analyze the current and forecast market size of the global in-vitro diagnostics market for major regions/countries including North America (US, Canada, Rest of North of America), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific) and Rest of World (Brazil, Others) Define and analyze the competitive landscape of the global in-vitro diagnostics market and the growth strategies adopted by the market players to sustain in the fast

Analyzing historical market, estimation of the current market and forecasting the future market for Global In-Vitro Diagnostics were the three major steps undertaken to create and analyze the overall adoption of in-vitro diagnostic services in major regions/countries. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the In-Vitro Diagnostics technology. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of In-Vitro Diagnostics market globally. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the overall market size of segments and sub-segments of the technology. Detailed methodology is explained below: Analysis of Historical Market Size Step 1: In-Depth Study of Secondary Sources: Detail secondary study was conducted to obtain the historical market size of the Global In-Vitro Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publications. For economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used. Step 2: Market Segmentation: After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global In-Vitro Diagnostics technology. Major segments included in the report are product, techniques, applications, end-users and usability. Step 3: Factor Analysis: After acquiring the historical market size of different segments detailed factor analysis was conducted to estimate the current market size of the Global In-Vitro Diagnostics technology. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global In-Vitro Diagnostics technology and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied. Current Market Size Estimate & Forecast Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews. Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, opportunities and trends. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments of the technology. The research methodology adopted to estimate the market size encompasses: The industry’s market size, in terms of value and rate of adoption of In-Vitro Diagnostics globally

All percentage shares, splits, and breakdowns of market segments and sub-segments

Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global In-Vitro Diagnostics market Market Size and Share Validation Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarised, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights. Split of Primary Participants Market Engineering Data triangulation technique was employed to complete the overall market engineering process and to arrive precise statistical numbers of each segment and sub-segment pertaining to the Global In-Vitro Diagnostics market. Data was split into several segments post studying various parameters and trends in areas such as product, techniques, applications, end-user, usability and regions such as North America, Europe, Asia-Pacific and Rest of the World. Main objective of the In-Vitro Diagnostics Market Study The current & future market trends of the Global In-Vitro Diagnostics market are pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market, providing a platform for the industrial participant to exploit the untapped market to benefit as first-mover advantage. Other quantitative goals of the studies include: Analyze the current and forecast market size of the global in-vitro diagnostics market in terms of value (US$)

Analyze the current and forecast market size of different segments and sub-segments of the global in-vitro diagnostics market

To analyze the revenue and business models of the market players in the industry

To understand the initiatives undertaken by diagnostics companies Vs. service providers to increase the overall analysis of in-vitro diagnostics in major regions

Define and describe the segments and sub-segments considered in the evaluation of the global in-vitro diagnostics market and anticipate potential risk associated with the market

Define and analysis of the government regulations for diagnostics

Analyze the current and forecast market size of the global in-vitro diagnostics market for major regions/countries including North America (US, Canada, Rest of North of America), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific) and Rest of World (Brazil, Others) Define and analyze the competitive landscape of the global in-vitro diagnostics market and the growth strategies adopted by the market players to sustain in the fast